Innova Captab Limited (NSE:INNOVACAP)

Market Cap	38.80B
Revenue (ttm)	14.94B
Net Income (ttm)	1.32B
Shares Out	57.22M
EPS (ttm)	23.13
PE Ratio	29.31
Forward PE	24.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,793,841
Average Volume	201,290
Open	654.20
Previous Close	654.20
Day's Range	649.80 - 764.95
52-Week Range	624.00 - 1,099.00
Beta	-0.38
RSI	44.02
Earnings Date	Jan 23, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2024, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.